Oxford Endovascular
Oxford
About Oxford Endovascular
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $28.4M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: oxfordendovascular.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/oxford-endovascular-128121 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.